On January 2, 2022, Arbela Laboratories announced the launch of its Bioprocess Development and Piloting service in conjunction with global leading Pichia Pastoris experts.
The Bioprocess Development and Piloting service is aimed at start-ups and mature businesses, universities, government labs and other institutions that have developed novel P. pastors strains capable of generating recombinant proteins and other fermentation products. While many of those businesses and labs have great expertise engineering P. pastors’ yeast, they oftentimes lack the skills or facilities to develop the methods that enable scaling from the lab bench to the pilot stage needed to provide customer samples and bridge to production.
Arbela’s Bioprocess Development and Piloting service brings together global experts and world class facilities to address that need and accelerate our customers product to the market.
About Arbela Labs
Arbela Labs (www.arbelalabs.com) is a New Jersey-based company focused on increasing the scale and reducing the costs of biomanufacturing using its methanol-fed Pichia platform and end-to-end systems engineering. Our goal is to economically produce proteins and other biomolecules for our customers at unprecedented volume while enabling a revolution in protein production for human and animal nutrition without the environmental downside of current practices.
